Interview: Jean-Philippe Gentès – President & CEO, Sterinova, Canada

Jean-Philippe Gentès, President, and CEO of the rapidly growing ready-to-use injectable manufacturer Sterinova, shares his ideas on the ‘Made in Canada’ label, innovation in North America and the pros and cons of pricing pressures in healthcare. Sterinova is a prime example of Made in Canada innovation, although Canadian innovation sometimes slips under the radar in North America. Are Canadians perhaps too humble to promote themselves on the international stage?
"Price decreases are a good thing for Canadian citizens as it reduces their financial burden, but unfortunately, it has knock-on effects for pharmaceutical companies, especially those with highly innovative portfolios."
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Already a member? Sign In

Related Interviews

Latest Report